Piramal Critical Care
Lucio Fumi's work experience includes holding the position of Chief Executive Officer at Wyfold Medical from 1998 to present. In 2019, they became the Director of Medical Affairs at Piramal Critical Care Inc., overseeing the company's full portfolio of products. Prior to this, they served as the Medical Director at TENSIVE from 2018 to 2022. From 2015 to 2016, Lucio was the Head of Medical Affairs at Terumo Medical Corporation. Lucio also held the position of Director of Liver Cancer, Interventional Oncology at BTG from 2012 to 2015. Earlier in their career, Lucio served as Chief Medical Officer at Clasado Biosciences, BioPheresis, and RanD Biotech. Lucio also worked as the Medical Director at Astellas Pharma and Danone.
Lucio Fumi obtained their Doctor of Medicine (MD) degree in Medicine and Surgery from Università degli Studi di Trieste. Lucio completed this degree program from 1975 to 1983. Later, from 1997 to 1999, Lucio attended Cardiff University / Prifysgol Caerdydd, where they pursued a field of study in Pharmaceutical Medicine. No specific degree name is mentioned for this program.
This person is not in any offices
Piramal Critical Care
Piramal Critical Care (PCC), a business division of Piramal Pharma Limited (PPL) is one of the leaders in inhaled anesthetics and a global player in hospital generics. “Saving and improving patients’ lives” is much more than a purpose statement to us. We are motivated by our vision of commitment to delivering critical care solutions for patients and healthcare providers, while achieving sustainable and profitable growth for all the stakeholders. Piramal Critical Care maintains a wide presence across the US, Europe and more than 100 countries across the globe. Our product portfolio includes inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, injectable anti-infectives, oral therapy for Type I Gaucher and Niemann pick Type C disease, anticholinergic, plasma volume expander, non-depolarizing neuromuscular blocking agent, depolarizing skeletal muscle relaxant and an anxiolytic, sedative and pain medication. Our products include Sevoflurane, Desflurane, Isoflurane, Halothane, Gablofen® (Baclofen Injection), MITIGO™(Morphine Sulfate), Dipidolor® (Piritramide), Sublimaze® (Fentanyl Citrate), Rapifen® (Alfentanil Hydrochloride), Sufenta® (Sufentanil Citrate), Hypnomidate®(Etomidate), Ampicillin and Sulbactam for Injection, USP, Cefepime for Injection, USP, Ceftriaxone for Injection, USP, Linezolid Injection, Ampicillin for Injection, USP, Piperacillin and Tazobactam for Injection, USP, Yargesa™ (Miglustat), Glycopyrrolate, Haemaccel, Rocuronium Bromide Injection, Succinylcholine Chloride Injection, USP, Dexmedetomidine Injection, USP, Dexmedetomidine HCl in 0.9% Sodium Chloride Injection (RTU*) and Propofol- Lipuro emulsion for Injection or Infusion. PCC has strong manufacturing and process development experience. PCC has fully owned manufacturing facilities in Bethlehem, PA, USA and Digwal, India. Customer centricity is the cornerstone of our business. *RTU Ready to use